0 CHECKOUT

Depression - Pipeline Review, H1 2015

  • ID: 3106254
  • January 2015
  • 455 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • AB Science
  • AstraZeneca PLC
  • Delpor, Inc.
  • GliaCure Inc.
  • Methylation Sciences Inc.
  • Omeros Corporation
  • MORE

Depression - Pipeline Review, H1 2015

Summary

This, ‘Depression - Pipeline Review, H1 2015’, provides an overview of the Depression’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Depression and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AB Science
  • AstraZeneca PLC
  • Delpor, Inc.
  • GliaCure Inc.
  • Methylation Sciences Inc.
  • Omeros Corporation
  • MORE

Introduction
Depression Overview
Therapeutics Development
Depression - Therapeutics under Development by Companies
Depression - Therapeutics under Investigation by Universities/Institutes
Depression - Pipeline Products Glance
Depression - Products under Development by Companies
Depression - Products under Investigation by Universities/Institutes
Depression - Companies Involved in Therapeutics Development
Depression - Therapeutics Assessment
Drug Profiles
Depression - Recent Pipeline Updates
Depression - Dormant Projects
Depression - Discontinued Products
Depression - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Depression, H1 2015
Number of Products under Development for Depression - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Development by Companies, H1 2015 (Contd..9)
Products under Development by Companies, H1 2015 (Contd..10)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Depression - Pipeline by AB Science, H1 2015
Depression - Pipeline by Acetylon Pharmaceuticals, Inc., H1 2015
Depression - Pipeline by Ache Laboratorios Farmaceuticos S/A, H1 2015
Depression - Pipeline by Adamas Pharmaceuticals, Inc., H1 2015
Depression - Pipeline by Adamed Sp. z o.o., H1 2015
Depression - Pipeline by Addex Therapeutics Ltd, H1 2015
Depression - Pipeline by Alkermes Plc, H1 2015
Depression - Pipeline by Allergan, Inc., H1 2015
Depression - Pipeline by Anavex Life Sciences Corp., H1 2015
Depression - Pipeline by Angelini Group, H1 2015
Depression - Pipeline by Angita B.V., H1 2015
Depression - Pipeline by Ascendis Pharma A/S, H1 2015
Depression - Pipeline by AstraZeneca PLC, H1 2015
Depression - Pipeline by Avanir Pharmaceuticals, Inc., H1 2015
Depression - Pipeline by Azevan Pharmaceuticals, Inc., H1 2015
Depression - Pipeline by Beech Tree Labs, Inc., H1 2015
Depression - Pipeline by BioCrea GmbH, H1 2015
Depression - Pipeline by Bionomics Limited, H1 2015
Depression - Pipeline by Boehringer Ingelheim GmbH, H1 2015
Depression - Pipeline by Bristol-Myers Squibb Company, H1 2015
Depression - Pipeline by Calico LLC, H1 2015
Depression - Pipeline by Cerecor Inc., H1 2015
Depression - Pipeline by Clera Inc., H1 2015
Depression - Pipeline by Concert Pharmaceuticals, Inc., H1 2015
Depression - Pipeline by Convergence Pharmaceuticals Ltd., H1 2015
Depression - Pipeline by D-Pharm Ltd., H1 2015
Depression - Pipeline by Delpor, Inc., H1 2015
Depression - Pipeline by Domain Therapeutics SA, H1 2015
Depression - Pipeline by e-Therapeutics plc, H1 2015
Depression - Pipeline by Edgemont Pharmaceuticals, LLC, H1 2015
Depression - Pipeline by Eisai Co., Ltd., H1 2015
Depression - Pipeline by Eli Lilly and Company, H1 2015
Depression - Pipeline by Euthymics Bioscience, Inc., H1 2015
Depression - Pipeline by F. Hoffmann-La Roche Ltd., H1 2015
Depression - Pipeline by GlaxoSmithKline plc, H1 2015
Depression - Pipeline by GliaCure Inc., H1 2015
Depression - Pipeline by H. Lundbeck A/S, H1 2015
Depression - Pipeline by Heptares Therapeutics Ltd., H1 2015
Depression - Pipeline by HolsboerMaschmeyer NeuroChemie GmbH, H1 2015
Depression - Pipeline by Intas Pharmaceuticals Ltd., H1 2015
Depression - Pipeline by Intra-Cellular Therapies, Inc., H1 2015
Depression - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H1 2015
Depression - Pipeline by Johnson & Johnson, H1 2015
Depression - Pipeline by KemPharm, Inc., H1 2015
Depression - Pipeline by KunWha Pharmaceutical Co., Ltd., H1 2015
Depression - Pipeline by Lead Discovery Center GmbH, H1 2015
Depression - Pipeline by Luye Pharma Group Ltd., H1 2015
Depression - Pipeline by M et P Pharma AG, H1 2015
Depression - Pipeline by Mapreg S.A.S., H1 2015
Depression - Pipeline by MarcoPolo Pharmaceuticals SA, H1 2015
Depression - Pipeline by Meta-IQ ApS, H1 2015
Depression - Pipeline by Methylation Sciences Inc., H1 2015
Depression - Pipeline by MI.TO. Technology S.r.L., H1 2015
Depression - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015
Depression - Pipeline by Mnemosyne Pharmaceuticals, Inc., H1 2015
Depression - Pipeline by Naurex, Inc., H1 2015
Depression - Pipeline by Nektar Therapeutics, H1 2015
Depression - Pipeline by NeRRe Therapeutics Ltd, H1 2015
Depression - Pipeline by Neuralstem, Inc., H1 2015
Depression - Pipeline by NeuroNascent, Inc., H1 2015
Depression - Pipeline by Newron Pharmaceuticals S.p.A., H1 2015
Depression - Pipeline by nLife Therapeutics, S.L., H1 2015
Depression - Pipeline by Omeros Corporation, H1 2015
Depression - Pipeline by Otsuka Holdings Co., Ltd., H1 2015
Depression - Pipeline by Pfizer Inc., H1 2015
Depression - Pipeline by Pherin Pharmaceuticals, Inc., H1 2015
Depression - Pipeline by PsychoGenics, Inc., H1 2015
Depression - Pipeline by Reviva Pharmaceuticals Inc., H1 2015
Depression - Pipeline by Richter Gedeon Nyrt., H1 2015
Depression - Pipeline by Saniona AB, H1 2015
Depression - Pipeline by SK Biopharmaceuticals Co., Ltd., H1 2015
Depression - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H1 2015
Depression - Pipeline by Sunovion Pharmaceuticals Inc., H1 2015
Depression - Pipeline by Supernus Pharmaceuticals, Inc., H1 2015
Depression - Pipeline by Suven Life Sciences Ltd., H1 2015
Depression - Pipeline by Taisho Pharmaceutical Co., Ltd., H1 2015
Depression - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015
Depression - Pipeline by Tesaro, Inc., H1 2015
Depression - Pipeline by Tetra Discovery Partners LLC, H1 2015
Depression - Pipeline by Teva Pharmaceutical Industries Limited, H1 2015
Depression - Pipeline by Trevena, Inc., H1 2015
Depression - Pipeline by VistaGen Therapeutics , Inc., H1 2015
Depression - Pipeline by Zhejiang Huahai Pharmaceutical Co., Ltd., H1 2015
Depression - Pipeline by Zogenix, Inc., H1 2015
Depression - Pipeline by Zysis Limited, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Depression Therapeutics - Recent Pipeline Updates, H1 2015
Depression - Dormant Projects, H1 2015
Depression - Dormant Projects (Contd..1), H1 2015
Depression - Dormant Projects (Contd..2), H1 2015
Depression - Dormant Projects (Contd..3), H1 2015
Depression - Dormant Projects (Contd..4), H1 2015
Depression - Dormant Projects (Contd..5), H1 2015
Depression - Dormant Projects (Contd..6), H1 2015
Depression - Dormant Projects (Contd..7), H1 2015
Depression - Dormant Projects (Contd..8), H1 2015
Depression - Dormant Projects (Contd..9), H1 2015
Depression - Dormant Projects (Contd..10), H1 2015
Depression - Dormant Projects (Contd..11), H1 2015
Depression - Dormant Projects (Contd..12), H1 2015
Depression - Dormant Projects (Contd..13), H1 2015
Depression - Dormant Projects (Contd..14), H1 2015
Depression - Dormant Projects (Contd..15), H1 2015
Depression - Dormant Projects (Contd..16), H1 2015
Depression - Dormant Projects (Contd..17), H1 2015
Depression - Dormant Projects (Contd..18), H1 2015
Depression - Dormant Projects (Contd..19), H1 2015
Depression - Discontinued Products, H1 2015
Depression - Discontinued Products (Contd..1), H1 2015
Depression - Discontinued Products (Contd..2), H1 2015
Depression - Discontinued Products (Contd..3), H1 2015
Depression - Discontinued Products (Contd..4), H1 2015
Depression - Discontinued Products (Contd..5), H1 2015
Depression - Discontinued Products (Contd..6), H1 2015

List of Figures
Number of Products under Development for Depression, H1 2015
Number of Products under Development for Depression - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

AB Science
Acetylon Pharmaceuticals, Inc.
Ache Laboratorios Farmaceuticos S/A
Adamas Pharmaceuticals, Inc.
Adamed Sp. z o.o.
Addex Therapeutics Ltd
Alkermes Plc
Allergan, Inc.
Anavex Life Sciences Corp.
Angelini Group
Angita B.V.
Ascendis Pharma A/S
AstraZeneca PLC
Avanir Pharmaceuticals, Inc.
Azevan Pharmaceuticals, Inc.
Beech Tree Labs, Inc.
BioCrea GmbH
Bionomics Limited
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Calico LLC
Cerecor Inc.
Clera Inc.
Concert Pharmaceuticals, Inc.
Convergence Pharmaceuticals Ltd.
D-Pharm Ltd.
Delpor, Inc.
Domain Therapeutics SA
e-Therapeutics plc
Edgemont Pharmaceuticals, LLC
Eisai Co., Ltd.
Eli Lilly and Company
Euthymics Bioscience, Inc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
GliaCure Inc.
H. Lundbeck A/S
Heptares Therapeutics Ltd.
HolsboerMaschmeyer NeuroChemie GmbH
Intas Pharmaceuticals Ltd.
Intra-Cellular Therapies, Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Johnson & Johnson
KemPharm, Inc.
KunWha Pharmaceutical Co., Ltd.
Lead Discovery Center GmbH
Luye Pharma Group Ltd.
M et P Pharma AG
Mapreg S.A.S.
MarcoPolo Pharmaceuticals SA
Meta-IQ ApS
Methylation Sciences Inc.
MI.TO. Technology S.r.L.
Mitsubishi Tanabe Pharma Corporation
Mnemosyne Pharmaceuticals, Inc.
Naurex, Inc.
Nektar Therapeutics
NeRRe Therapeutics Ltd
Neuralstem, Inc.
NeuroNascent, Inc.
Newron Pharmaceuticals S.p.A.
nLife Therapeutics, S.L.
Omeros Corporation
Otsuka Holdings Co., Ltd.
Pfizer Inc.
Pherin Pharmaceuticals, Inc.
PsychoGenics, Inc.
Reviva Pharmaceuticals Inc.
Richter Gedeon Nyrt.
Saniona AB
SK Biopharmaceuticals Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
Sunovion Pharmaceuticals Inc.
Supernus Pharmaceuticals, Inc.
Suven Life Sciences Ltd.
Taisho Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited
Tesaro, Inc.
Tetra Discovery Partners LLC
Teva Pharmaceutical Industries Limited
Trevena, Inc.
VistaGen Therapeutics , Inc.
Zhejiang Huahai Pharmaceutical Co., Ltd.
Zogenix, Inc.
Zysis Limited

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S